Covered recipient · General Payments record
JENNIFER E ALLEN
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$3,565.88
- Reported across 114 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $800.00 | 4 |
| Food and Beverage | $218.80 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MIMEDX Group, Inc. | $800.00 | 4 |
| Astellas Pharma US Inc | $73.16 | 4 |
| Organon LLC | $43.68 | 3 |
| Exeltis, USA Inc. | $31.23 | 2 |
| Sage Therapeutics, Inc. | $19.65 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $18.97 | 1 |
| PFIZER INC. | $16.78 | 1 |
| Minerva Surgical, Inc | $15.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $17.49 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139277430 | CMS |
| Astellas Pharma US Inc | $22.57 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139268766 | CMS |
| Astellas Pharma US Inc | $15.04 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139326168 | CMS |
| Astellas Pharma US Inc | $18.06 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139276544 | CMS |
| Exeltis, USA Inc. | $16.00 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149984648 | CMS |
| Exeltis, USA Inc. | $15.23 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149984650 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $18.97 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154680007 | CMS |
| MIMEDX Group, Inc. | $200.00 | 05/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140254353 | CMS |
| MIMEDX Group, Inc. | $200.00 | 06/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140254355 | CMS |
| MIMEDX Group, Inc. | $200.00 | 10/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140254357 | CMS |
| MIMEDX Group, Inc. | $200.00 | 12/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140254359 | CMS |
| Minerva Surgical, Inc | $15.33 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1085612985 | CMS |
| Organon Llc | $19.55 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136234234 | CMS |
| Organon Llc | $9.95 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136234230 | CMS |
| Organon Llc | $14.18 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136234238 | CMS |
| PFIZER INC. | $16.78 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131770438 | CMS |
| Sage Therapeutics, Inc. | $19.65 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120404346 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.